从血液检测结果的年龄估计使用随机森林模型
Satomi Kodera1, Osamu Yokoi2, Masaki Kaneko1,3
1KYB Medical Service Co., LTD, Tokyo, Japan.
Journal of clinical laboratory analysis
|June 12, 2025
概括
使用随机森林模型从查数据中估计生物年龄,可以准确地衡量物理衰老. 这种"血液年龄"可以帮助识别与衰老相关的健康问题,如代谢综合征.
科学领域:
- 预防医学 预防医学
- 老年学是一门学科.
- 生物标志物 生物标志物
背景情况:
- 查数据在了解衰老和健康方面发挥着至关重要的作用.
- 准确的健康评估所需的数据项数量需要澄清.
研究的目的:
- 从查数据中估计时间表年龄.
- 为了确定可靠的年龄估计所需的数据项的最小数量.
- 探索预估年龄在预防医学中的有用性.
主要方法:
- 采用了一个随机森林模型.
- 分析了11554名接受查测试的个人 (0-95岁) 的数据.
- 分析包括血液,尿液和唾液测试.
主要成果:
- 使用71个数据项实现了高精度 (R2 = 0.7010).
- 精度仍然很高 (R2 = 0.6937) 有15个项目.
- 在不到800个数据集或7个数据项的情况下,准确性显著下降.
结论:
- 从血液数据 (血液年龄) 估计年龄是身体衰老的准确指标.
- 血液年龄和其他生物年龄估计显示出研究与衰老相关疾病的前景.
- 这种方法可以帮助探索诸如代谢和脆弱综合征等问题.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
730
相关概念视频
Survival Tree
66
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
66
Actuarial Approach
64
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
64
Wald-Wolfowitz Runs Test I
615
The Wald-Wolfowitz test, also known as the runs test, is a nonparametric statistical test used to assess the randomness of a sequence of two different types of elements (e.g., positive/negative values, successes/failures). It examines whether the order of the elements in a sequence is random or if there is a pattern or trend present. This nonparametric test applies to any ordered data despite the population and sample data distribution, even if a higher sample size is available.
The test works...
The test works...
615
Wald-Wolfowitz Runs Test II
193
The Wald-Wolfowitz runs test, commonly referred to as the runs test, is a nonparametric test used to assess the randomness of ordered data. The test evaluates the number of runs, which are consecutive sequences of similar elements within the data. If the number of runs is significantly higher or lower than expected, the data is considered non-random, indicating a detectable pattern or structure.
For binary data, runs are identified using symbols such as + and −, or equivalently, 1s and...
For binary data, runs are identified using symbols such as + and −, or equivalently, 1s and...
193
Bootstrapping
584
The term "bootstrap" originated in the 19th century as a metaphor for self-improvement or achieving something independently, without external assistance. This concept extends to statistical bootstrapping, a self-contained method for estimating population parameters through resampling, even though it can be computationally intensive. Developed by the American statistician Dr. Bradley Efron in 1979, bootstrapping provides a robust way to perform inference when the original sample size is...
584
Kaplan-Meier Approach
107
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
107
